Abbott Laboratories
ABT:NYSE
| Last | Change / % Change | Dividend Yield | Volume | Avg Volume (10 day) |
| 37.76 | 0.28 0.75% | 1.48% | 5,429,898 | 7.2M |
Market data is delayed by at least 20 minutes.
Latest News Headlines for Abbott Laboratories
Abbott to Present at Deutsche Bank 38th Annual Health Care Conference
ABBOTT PARK, Ill., May 22, 2013 /PRNewswire/ -- Abbott (NYSE: ABT) will participate in the Deutsche Bank 38(th) Annual Health Care Conference on Wednesday, May 29, 2013. Thomas C. Freyman, executive vice president, finance and chief financial officer, and Scott White, senior vice president, international nutrition, will present at 1:10 p.m. Central time.
Abbott Announces CE Mark for World's Longest Coronary Drug Eluting Stent
View more recent headlines
- XIENCE Xpedition(TM) 48 Leverages Proven Design and Clinical Outcomes of the XIENCE Family of Drug Eluting Stents
- Has the Potential to Reduce Overall Procedural Costs
- Very Long Lesions Most Often Seen in Patients with Diabetes
Company Background
Abbott Laboratories (Abbott), is engaged in the discovery, development, manufacture, and sale of a portfolio of science-based health care products. Abbott operates in four business segments: diagnostics, medical devices, nutritionals and generic pharmaceuticals. Geographically, 30% of its revenue is generated in the United States; 30% in Western Europe, Canada, Japan and Australia, and 40% in the economies, including India, China, Russia and Brazil. In January 2013, the Company completed the separation of its research-based pharmaceuticals business, which became AbbVie, a new independent biopharmaceutical company.
Bid/Size -- / -- | Ask/Size -- / -- |
Price Open 37.17 | Previous Close 37.48 |
Day High 37.84 | Day Low 37.11 |
52wk High/Date 72.47 / 10/16/2012 | 52wk Low/Date 31.64 / 1/2/2013 |
% off 52wk High -47.90% | % off 52wk Low 19.34% |
Beta (5 Yr) 0.4 | Market Capitalization 58.9B |
Shares Outstanding 1.6B | Volatility Avg 16.68 |
EPS(TTM) 0.49 | P/E Ratio 77.2x |
Dividend Announcement 2/15/2013 | Dividend Yield 1.48% |
Ex-Date 4/11/2013 | Date of Record 4/15/2013 |
Payable 0.14 - QRTR | Payable Date 5/15/2013 |
Last Trade as of 5/24/2013 4:04 PM ET | |
ABT Abbott Laboratories vs. Peers
| Peers | |
|---|---|
ABT Abbott Laboratories | 20.49% |
Johnson & Johnson | 23.85% |
Pfizer Inc. | 15.79% |
ABT Abbott Laboratories | 1.48% |
Johnson & Johnson | 3.04% |
Pfizer Inc. | 3.31% |
ABT Abbott Laboratories | 0.75% |
Johnson & Johnson | -0.45% |
Pfizer Inc. | -0.24% |